SALVATORE, Teresa
 Distribuzione geografica
Continente #
EU - Europa 8.251
NA - Nord America 3.426
AS - Asia 2.911
SA - Sud America 477
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 15.108
Nazione #
RU - Federazione Russa 5.368
US - Stati Uniti d'America 3.337
SG - Singapore 1.015
IE - Irlanda 872
CN - Cina 846
HK - Hong Kong 510
IT - Italia 408
BR - Brasile 394
GB - Regno Unito 363
UA - Ucraina 359
DE - Germania 281
SE - Svezia 185
VN - Vietnam 122
FR - Francia 120
FI - Finlandia 110
KR - Corea 107
IN - India 83
TR - Turchia 80
GR - Grecia 69
MX - Messico 39
JP - Giappone 38
CA - Canada 32
AR - Argentina 29
AT - Austria 27
IR - Iran 22
BE - Belgio 18
BD - Bangladesh 17
NL - Olanda 16
CO - Colombia 14
ES - Italia 13
EC - Ecuador 12
ZA - Sudafrica 12
PL - Polonia 11
VE - Venezuela 10
ID - Indonesia 9
CZ - Repubblica Ceca 8
IQ - Iraq 8
PK - Pakistan 8
JM - Giamaica 7
MA - Marocco 7
UZ - Uzbekistan 7
PE - Perù 6
EG - Egitto 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
LB - Libano 2
PA - Panama 2
PH - Filippine 2
AN - Antille olandesi 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 15.108
Città #
Moscow 1.875
Dublin 860
Jacksonville 544
Hong Kong 509
Chandler 479
Santa Clara 428
Singapore 427
Princeton 125
The Dalles 111
Seoul 105
Ashburn 100
Hefei 100
Beijing 99
Medford 93
Ann Arbor 88
Dallas 87
Roxbury 82
Nanjing 71
New York 71
Bengaluru 66
Boardman 57
San Mateo 54
Bremen 51
Munich 50
Caserta 48
Naples 48
Jinan 45
Wilmington 45
Ho Chi Minh City 42
São Paulo 40
Cambridge 39
Woodbridge 38
Los Angeles 31
Des Moines 30
Nanchang 23
Düsseldorf 21
Tianjin 20
Kunming 19
Brussels 18
Torre Del Greco 18
Hanoi 17
Mountain View 16
Zanjan 16
Shenyang 15
Milan 13
Taiyuan 13
Changsha 12
Helsinki 12
Houston 12
Salerno 12
Vienna 12
Guangzhou 11
Lanzhou 11
Norwalk 11
Nuremberg 11
Boston 10
Brooklyn 10
Frankfurt am Main 10
Montreal 10
Napoli 10
Rio de Janeiro 10
Andover 9
Falkenstein 9
Taizhou 9
Dong Ket 8
Haikou 8
Johannesburg 8
Rome 8
Warsaw 8
Amsterdam 7
Da Nang 7
Ningbo 7
Sacramento 7
Seattle 7
Shanghai 7
Tashkent 7
Turku 7
Washington 7
Zhengzhou 7
Atlanta 6
Aversa 6
Biên Hòa 6
Campinas 6
Chennai 6
Fairfield 6
Haiphong 6
Lahore 6
Mexico 6
Mexico City 6
Stockholm 6
Toronto 6
Amman 5
Belo Horizonte 5
Bogotá 5
Brasília 5
Chicago 5
Hangzhou 5
Hanover 5
Hebei 5
Hải Dương 5
Totale 7.565
Nome #
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 211
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 193
Lo squatting test nella valutazione della neuropatia diabetica 175
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 172
Diagnosi e trattamento precoce della vasculopatia cerebrale cronica nel paziente diabetico 172
What changed in the Italian internal medicine and geriatric wards during the lockdown 168
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 161
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 161
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 159
Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity 154
Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent 154
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 154
Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin 152
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 150
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 150
ANORECTAL FUNCTION IN DIABETES MELLITUS 148
Decreased insulin clearance as a feature of essential hypertension 147
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP 144
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 142
Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients 141
ALTERATIONS OF RECTAL SENSITIVITY IN DIABETIC PATIENTS 141
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 141
A double-blind controlled study on the effect of tolrestat on diabetic autonomic neuropathy 140
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 135
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 132
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 132
Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus 131
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 129
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 129
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 129
Aumentata prevalenza di Diabete tipo-2 nelle famiglie di individui affetti da Diabete tipo-1 Studio di 5 anni condotto nella Regione Campania 129
LO “SQUATTING” TEST NELLA VALUTAZIONE DELLA NEUROPATIA AUTONOMICA DIABETICA 129
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 128
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 126
Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects 125
[Obesity and myocardial infarction] 125
Dual effect of beta-endorphin on insulin secretion in man 123
Cardiovascular benefits from gliflozins: Effects on endothelial function 123
An unusual case of primary systemic amyloidosis 122
Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus 121
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist 121
HCC and molecular targeting therapies: Back to the future 121
Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study 120
LA RIDUZIONE DELLA CLEARANCE METABOLICA DELL’INSULINA CONTRIBUISCE ALL’IPERINSULINEMIA DEL PAZIENTE CON IPERTENSIONE ESSENZIALE 120
Effect of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 120
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 119
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 119
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 117
Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? 117
Is the common presence of glucose intolerance in old age a reliable index for the subsequent occurrence of fasting hyperglycemia? 117
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 116
Comment on: Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma 116
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment 116
The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people 112
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 112
Low protein alimentation normalizes renal haemodynamic response to acute protein ingestion in type 1 diabetic children 111
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 108
[Large mediastinal mass of heterotopic thyroid tissue: a case report and review of literature] 108
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 106
Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia 105
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 104
An unforseen type 1 diabetes does make a complex diagnosis 104
VALUTAZIONE DEI NUOVI CRITERI CLASSIFICATIVI DEL DIABETE MELLITO NELL’ETA’ AVANZATA 103
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 103
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 102
Sensitivity to beta-endorphin as a cause of human obesity 102
Metabolic modifications induced by a combined insulin-glucose intravenous infusion before and after a protein-supplemented fast in obese subjects 102
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 102
Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects 101
Sensorimotor evaluation of ano-rectal complex in diabetes mellitus. 101
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 101
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 100
Evaluation of various lung physiopathology tests in subjects with chronic bronchitis before and after administration of salbutamol 99
Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin 98
[Non-insulin-dependent diabetes in young subjects] 98
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 98
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 97
Progress in the oral treatment of type 2 diabetes: update on DPP-IV inhibitors. 97
INFLUENZA DELLO SFORZO SULLA PaO2 IN SOGGETTI CON SINDROME RESTRITTIVA 97
VALUTAZIONE DELLA SECREZIONE ESOCRINA PANCREATICA MEDIANTE LAURIL E BT-PAVA TEST NEL DIABETE MELLITO 97
ESISTE UNA NETTA SEPARAZIONE NELLA PATOGENESI DELL’IPERGLICEMIA TRA DIABETICI INSULINO-DIPENDENTI E DIABETICI NON-INSULINO DIPENDENTI? 97
Fast extramedullary pleural spread in a new diagnosis of multiple myeloma 97
UPPER DIGESTIVE TRACT INVOLVEMENT IN TYPE 2 (NON INSULIN DIPENDENT) DIABETES: PH-MANOMETRIC AND ENDOSCOPIC STUDY 96
Metabolic clearance rate of insulin in offspring of patients with non-insulin-dependente diabetes (NIDDM). 96
Valutazione della secrezione esocrina pancreatica mediante Lauril e BT-PABA test nel diabete mellito 95
Heart failure and chronic kidney disease in a registry of internal medicine wards 95
HETEROGENEITY IN THE PATHOPHYSIOLOGY OF INSULIN SECRETION IN NON-INSULIN DEPENDENT DIABETES 94
Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 94
VALUTAZIONE DELLA RIPOLARIZZAZIONE VENTRICOLARE MEDIANTE SQUATTING TEST IN SOGGETTI DIABETICI CON NEUROPATIA AUTONOMICA CARDIOVASCOLARE PARASIMPATICA 93
Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study 93
null 93
Increased VEGF Expression but Impaired VEGF Receptor Signaling In The Myocardium of Diabetic Type 2 Patients with Chronic Coronary Heart Disease 92
Opioid peptides and obesity 92
VALUTAZIONE DI ALCUNI TESTS DI FISIOPATOLOGIA POLMONARE IN SOGGETTI AFFETTI DA BRONCHITE CRONICA PRIMA E DOPO SOMMINISTRAZIONE DI SALBUTAMOLO 92
Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM 91
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial 91
Liver cirrhosis in type II diabetic patients does not worsen insulin resistance 91
Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia 91
Influenza della bromocriptina sull'omeostasi glucidica nel diabete mellito tipo II. 91
ETA’ E BARORIFLESSO: VALUTAZIONE DELLO SQUATTING TO STANDYNG TEST MEDIANTE FINAPRES 91
Totale 11.970
Categoria #
all - tutte 52.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021498 0 0 0 0 0 2 113 102 5 126 100 50
2021/2022878 73 5 10 34 301 13 10 22 25 55 104 226
2022/20231.770 150 63 30 156 160 140 5 102 849 26 35 54
2023/2024664 54 33 29 57 230 77 7 16 5 8 58 90
2024/20252.099 6 36 16 40 342 241 329 171 314 224 215 165
2025/20267.402 364 360 433 396 774 5.075 0 0 0 0 0 0
Totale 15.274